Learn exclusive information from the top leaders in this space who are only sharing information with you. These takeaways include the tools to:

• Utilize solid dispersion processes during our half-day devoted to amorphous formulation
• Predict absorption of new chemical entities within silico modeling
• Utilize Pharmaceutical Co-Crystals to enhance solubility and dissolution of insoluble APIs
• Maximize the systematic exposure of drugs in toxicology evaluations and early formulation
• Enhance the bioavailability of poorly soluble compounds using lipid-based formulations
• Investigate strategies to maintain your patent life-cycle

These products include

• Accoquat^® STEQ-90 (di–tallow TEA ester quaternary ammonium compounds) and
• Accoquat VEQ HF-90 (vegetable based TEA ester quaternary ammonium compounds).

These products offer excellent softening and anti-static properties in formulations and will leave a dry, subtle feel on the hand. To learn more about these and other ABITEC products, contact us at 800.555.1255 or sales@abiteccorp.com.

More About CleanGredients®

CleanGredients is an online database of cleaning ingredients — the online resource for green formulation®. CleanGredients aligns broad environmental and human health goals with the cleaning product industry’s business objectives and will support formulation of products with human and environmental health benefits, whether to meet corporate internal objectives, regulations, voluntary product recognition programs, or national and international eco-labels. CleanGredients is designed to:

1. help formulators identify ingredients that have potential environmental and human health and safety benefits, and
2. provide opportunity for manufacturers and producers of cleaning ingredients to showcase their ingredients with potential environmental and human health and safety benefits.

 At present, CleanGredients includes listings for surfactants, solvents, fragrances, and chelating agents. Modules for additional ingredient classes are in development. Key attribute data and the ingredient formulations are reviewed by an approved third-party, and carried out under confidentiality, providing verification of claims for the key ingredient attributes for ingredients without compromising proprietary formulations.

Additional information can be found on the CleanGredients website, www.cleangredients.org.

“This kind of partnership gives us access to basic science that we did not have the internal resources to commit to. By combining our expertise in this way we are providing real solutions to the pharmaceutical market, expanding our trustworthy reputation and ultimately building our brand. We have already had two peer reviewed articles published by Dr. Serajuddin and co-authored by Damon Dalrymple. We look at the long view of trends in drug formulization and delivery and help direct research that will solve problems for our industrial partners,” explains Dr. Kelemen.

The ABITEC strategic alliance is focusing on key areas such as providing soluble forms of drugs for research so they can be scientifically assessed for toxicology and efficacy and improved delivery systems for existing drugs with issues around bio compatibility and effective dosage. Damon, Donald and colleague Dr. Jim Williams, anticipate that by 2014, eight out of ten drugs will be based on biological proteins and their research is also taking them towards creating solid particles for oral treatment with drugs that could only previously be injected.

The speed with which ABITEC, its university partners and its industry clients are seeing results is relative. The journey to market for any drug is long and rightfully includes countless steps in research, testing and trials before it reaches the market but the collaborative partners play pivotal roles in ensuring that every step is a step in the right direction. The time, money and expertise that ABITEC invests in supporting the graduate students in its partnership program is a long term investment that pays dividends on many levels. “We are extremely pleased to be actively involved with the training of future pharmacology scientists and helping them complete their thesis and dissertations. We are building brand recognition and a bond between us and the scientist that could last the life of their entire career. We are extending the concept of strategic collaborations to embrace India and the UK and we are looking forward to great things to come,” concludes Dr. Kelemen.

Publications as a result of the strategic alliance with Dr. Serajuddin and St. John’s University:

•  DOI 10.1007s 11095-011-0541-3
• J. Excipients and Food Chem. 2 (3) 2011